Patents by Inventor Takanori Minami
Takanori Minami has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 7531499Abstract: The present invention provides a medicinal composition comprising (1) a pharmacologically active substance, (2) a drug absorbefacient and (3) a taurine compound or a polyamine. A taurine compound has an effect of suppressing or preventing damage of the intestinal mucous membrane, and therefore adding the taurine compound to a medicinal composition containing a pharmacologically active substance and a drug absorbefacient makes it possible to suppress or prevent damage of the intestinal mucosa. A polyamine improves the absorbability of pharmacologically active substances, and therefore adding the polyamine to a medicinal composition containing a pharmacologically active substance and a drug absorbefacient makes it possible to decrease the dose of the drug absorbefacient, thereby suppressing or preventing damage of the intestinal mucosa.Type: GrantFiled: December 15, 2004Date of Patent: May 12, 2009Assignee: Otsuka Pharmaceutical Co., Ltd.Inventors: Toshikiro Kimura, Kazutaka Higaki, Masateru Miyake, Takanori Minami
-
Patent number: 7008920Abstract: The present invention provides a medicinal composition comprising (1) a pharmacologically active substance, (2) a drug absorbefacient and (3) a taurine compound or a polyamine. A taurine compound has an efect of suppressing or preventing damage of the intestinal mucous membrane, and therefore adding the taurine compound to a medicinal composition containing a pharmacologically active substance and a drug absorbefacient makes it possible to suppress or prevent damage of the intestinal mucosa. A polyamine improves the absorbability of pharmacologically active substances, and therefore adding the polyamine to a medicinal composition containing a pharmacologically active substance and a drug absorbefacient makes it possible to decrease the dose of the drug absorbefacient, thereby suppressing or preventing damage of the intestinal mucosa.Type: GrantFiled: December 15, 2004Date of Patent: March 7, 2006Assignee: Otsuka Pharmaceutical Co., Ltd.Inventors: Toshikiro Kimura, Kazutaka Higaki, Masateru Miyake, Takanori Minami
-
Publication number: 20050100530Abstract: The present invention provides a medicinal composition comprising (1) a pharmacologically active substance, (2) a drug absorbefacient and (3) a taurine compound or a polyamine. A taurine compound has an efect of suppressing or preventing damage of the intestinal mucous membrane, and therefore adding the taurine compound to a medicinal composition containing a pharmacologically active substance and a drug absorbefacient makes it possible to suppress or prevent damage of the intestinal mucosa. A polyamine improves the absorbability of pharmacologically active substances, and therefore adding the polyamine to a medicinal composition containing a pharmacologically active substance and a drug absorbefacient makes it possible to decrease the dose of the drug absorbefacient, thereby suppressing or preventing damage of the intestinal mucosa.Type: ApplicationFiled: December 15, 2004Publication date: May 12, 2005Inventors: Toshikiro Kimura, Kazutaka Higaki, Masateru Miyake, Takanori Minami
-
Publication number: 20050095290Abstract: The present invention provides a medicinal composition comprising (1) a pharmacologically active substance, (2) a drug absorbefacient and (3) a taurine compound or a polyamine. A taurine compound has an efect of suppressing or preventing damage of the intestinal mucous membrane, and therefore adding the taurine compound to a medicinal composition containing a pharmacologically active substance and a drug absorbefacient makes it possible to suppress or prevent damage of the intestinal mucosa. A polyamine improves the absorbability of pharmacologically active substances, and therefore adding the polyamine to a medicinal composition containing a pharmacologically active substance and a drug absorbefacient makes it possible to decrease the dose of the drug absorbefacient, thereby suppressing or preventing damage of the intestinal mucosa.Type: ApplicationFiled: December 15, 2004Publication date: May 5, 2005Inventors: Toshikiro Kimura, Kazutaka Higaki, Masateru Miyake, Takanori Minami
-
Patent number: 6884768Abstract: The present invention provides a medicinal composition comprising (1) a pharmacologically active substance, (2) a drug absorbefacient and (3) a taurine compound or a polyamine. A taurine compound has an efect of suppressing or preventing damage of the intestinal mucous membrane, and therefore adding the taurine compound to a medicinal composition containing a pharmacologically active substance and a drug absorbefacient makes it possible to suppress or prevent damage of the intestinal mucosa. A polyamine improves the absorbability of pharmacologically active substances, and therefore adding the polyamine to a medicinal composition containing a pharmacologically active substance and a drug absorbefacient makes it possible to decrease the dose of the drug absorbefacient, thereby suppressing or preventing damage of the intestinal mucosa.Type: GrantFiled: June 14, 2002Date of Patent: April 26, 2005Assignee: Otsuka Pharmaceutical Co., Ltd.Inventors: Toshikiro Kimura, Kazutaka Higaki, Masateru Miyake, Takanori Minami
-
Publication number: 20040161407Abstract: The present invention provides a medicinal composition comprising (1) a pharmacologically active substance, (2) a drug absorbefacient and (3) a taurine compound or a polyamine. A taurine compound has an efect of suppressing or preventing damage of the intestinal mucous membrane, and therefore adding the taurine compound to a medicinal composition containing a pharmacologically active substance and a drug absorbefacient makes it possible to suppress or prevent damage of the intestinal mucosa. A polyamine improves the absorbability of pharmacologically active substances, and therefore adding the polyamine to a medicinal composition containing a pharmacologically active substance and a drug absorbefacient makes it possible to decrease the dose of the drug absorbefacient, thereby suppressing or preventing damage of the intestinal mucosa.Type: ApplicationFiled: December 12, 2003Publication date: August 19, 2004Inventors: Toshikiro Kimura, Kazutaka Higaki, Masateru Miyake, Takanori Minami
-
Patent number: 5462021Abstract: A hydrogen gas supply system for a hydrogen engine has a hydrogen gas cartridge which is detachably attached to the engine. The cartridge has a casing in which hydrogen gas storage alloy and a heating medium passage for heating the hydrogen gas storage alloy are housed. The engine is provided with a hydrogen gas supply passage which leads hydrogen gas discharged from the hydrogen gas cartridge to the engine, a heating medium supply passage which supplies heating medium to the heating medium passage in the hydrogen gas cartridge and a heating medium return passage through which the heating medium flows out of the hydrogen gas cartridge is returned. The hydrogen gas cartridge is provided with a hydrogen gas takeout port, a heating medium inlet and a heating medium outlet.Type: GrantFiled: July 5, 1994Date of Patent: October 31, 1995Assignee: Mazda Motor CorporationInventors: Takanori Minami, Noriaki Shiraishi, Tsutomu Shimizu, Kenji Takamuku, Yoshinori Tsushio, Yoshio Mizushima, Kazuyuki Yoshimoto, Masaki Kadokura